Spinal Tech

Globus Medical's short position dropped by 0.6 percent, according to Bull Report.

The Thuasne Group, owner of Townsend Design, acquired Quinn Medical.

In 2015, Medtech was involved in merger and acquisition activity as well as several transactions over $1 billion in value.

Paradigm Spine, a New York-based developer of lumbar spinal stenosis treatment solutions, published "Evaluation of Decompression and Interlaminar Stabilization Compared with Decompression and Fusion for the Treatment of Lumbar Spinal Stenosis: 5-year Follow-up of a Prospective, Randomized, Controlled Trial."

Israel-based ReWalk Robotics published the first case study of its ReWalk robotic exoskeleton in Spinal Cord Series and Cases, according to CNN Money. The study involved a patient who used the device for six months.

JPMorgan Chase restated Smith & Nephew stock's "neutral" rating, according to IRA Market Report.

Polyganics, a Netherlands-based medical technology company, received FDA clearance for its device that decreases neuroma formation, according to Plastics Today.

Stryker reported strong organic net sales in 2015 as well as a net sales increase in the fourth quarter.

A Minnesota appeals court revived the Medtronic shareholders' lawsuit against the company's merger with Covidien, according to a MedCity News report.

Stryker Vice President and CFO William R. Jellison will retire from his post after three years with the company.